Global Blood Therapeutics Inc. appointed Dawn Svoronos to its board.
Svoronos serves on the boards of Endocyte Inc., PTC Therapeutics Inc., Theratechnologies Inc. and Xenon Pharmaceuticals Inc. Previously, she acted as director and interim chief commercial officer of Medivation Inc. In addition, she was president of Merck Canada Inc.
South San Francisco, Calif.-based Global Blood Therapeutics is a clinical-stage biopharmaceutical company developing two therapies for the potential treatment of sickle cell disease.